These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26509821)

  • 1. The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.
    D'arena G; Grandone E; Di Minno MN; Musto P; Di Minno G
    Blood Transfus; 2016 May; 14(2):255-61. PubMed ID: 26509821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor eradication with rituximab in haemophilia: where do we stand?
    Franchini M; Mannucci PM
    Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
    Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
    Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired hemophilia a successfully treated with rituximab.
    D'Arena G; Grandone E; Di Minno MN; Musto P; Di Minno G
    Mediterr J Hematol Infect Dis; 2015; 7(1):e2015024. PubMed ID: 25745551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in the treatment of adult acquired hemophilia A: a systematic review.
    Franchini M
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):47-52. PubMed ID: 17236786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.
    Franchini M; Mengoli C; Lippi G; Targher G; Montagnana M; Salvagno GL; Zaffanello M; Cruciani M
    Haemophilia; 2008 Sep; 14(5):903-12. PubMed ID: 18671801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab in the treatment of acquired factor VIII inhibitors.
    Wiestner A; Cho HJ; Asch AS; Michelis MA; Zeller JA; Peerschke EI; Weksler BB; Schechter GP
    Blood; 2002 Nov; 100(9):3426-8. PubMed ID: 12384448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
    Leissinger C; Josephson CD; Granger S; Konkle BA; Kruse-Jarres R; Ragni MV; Journeycake JM; Valentino L; Key NS; Gill JC; McCrae KR; Neufeld EJ; Manno C; Raffini L; Saxena K; Torres M; Marder V; Bennett CM; Assmann SF
    Thromb Haemost; 2014 Sep; 112(3):445-58. PubMed ID: 24919980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for autoimmune haemophilia: a proposed treatment algorithm.
    Aggarwal A; Grewal R; Green RJ; Boggio L; Green D; Weksler BB; Wiestner A; Schechter GP
    Haemophilia; 2005 Jan; 11(1):13-9. PubMed ID: 15660983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose rituximab in the treatment of acquired haemophilia.
    Yao Q; Zhu X; Liu Y; Zhang F; Yuan T; Xu J; Wang X
    Hematology; 2014 Dec; 19(8):483-6. PubMed ID: 24611711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
    Braunert L; Bruegel M; Pfrepper C; Thiery J; Niederwieser D
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S40-3. PubMed ID: 21042682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.